MindMaze, which makes game-like rehabilitation tools for neurological conditions and injuries, announced a partnership with New York-based Mount Sinai Health System to offer a digital therapeutic program for stroke and concussion patients.
Under the partnership, Mount Sinai will use MindMaze's software and hardware to provide an outpatient rehab program followed by home-based digital care,...
London-based GripAble, which offers a platform for digital neurological and musculoskeletal rehabilitation, raised $11 million in Series A financing.
The round was led by IP Group and Parkwalk Advisors, bringing the startup's total raise to $17.5 million.
WHAT IT DOES
GripAble offers a handheld device that can be squeezed to assess grip strength. It pairs with an app in which users can play games...
Digital neurotherapy company MindMaze has scored $105 million in financing just months after it announced it had raised $125 million.
The latest round was led by Concord Health Partners with participation from AlbaCore Capital Group and Hambro Perks. According to Crunchbase, the company's total raise is now more than $340 million.
WHAT IT DOES
MindMaze provides game-like therapies and...
Digital neurotherapeutic platform MindMaze has raised $125 million in funding from AlbaCore Capital Group.
WHAT IT DOES
MindMaze provides digital therapies, like games, to treat and rehab patients with neurological conditions and brain injuries.
Its products include MindMotion Go, which helps improve motor skills, MindPod, which trains cognitive and motor skills for people with neurodegenerative...
MindMaze Healthcare, a digital neurotherapeutics company, is expanding its geographical footprint to patients in Latin America, the Middle East, Spain and Switzerland through a series of new partnerships.
The company has inked deals with Peruvian medical biotech company Surgicorp, Saudi Arabian medical company Alkholi, Spanish neurorehabilitation clinic Guttmann Barcelona and Swedish...
The human brain and the seemingly infinite number of health complications that can befall it are complex. As such, there aren’t universally agreed-upon therapies and treatments for conditions ranging from depression and chronic pain to stroke and Parkinson’s disease. But recent, rapid advances in neuroscience research and digital technology are enabling a new wave of tools to gain traction in...
